AI Terminal
Biocorp
Report Publication Announcement • Jan 5, 2022
1151_iss_2022-01-05_e7ec3f43-6bab-4990-91d1-d4f5bac4c91a.pdf
Report Publication Announcement
Open in ViewerOpens in native device viewer
BIOCORP : 2022 financial calendar
Issoire (France), January 5th, 2022, 6:00 pm CET – BIOCORP (FR0012788065 – ALCOR / Eligible PEA-PME), a French company specialized in the design, development, and manufacturing of innovative medical devices, presents its financial reporting schedule for 2022(1).
| Annonce | Date* |
|---|---|
| 2021 full-year results | Thursday, April 7th, 2022 Before the market opening |
| Annual shareholders meeting | Tuesday, May 17th, 2022 |
| 2022 first-half results | Thursday, September 29th, 2022 Before the market opening |
(1) This schedule is indicative and subject to change.
ABOUT BIOCORP
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This smart sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of patients with diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 70 employees. BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR).
For more information, please visit www.biocorpsys.com.
CONTACTS BIOCORP
Jacques Gardette Éric Dessertenne Sylvaine Dessard [email protected] [email protected]
Chairman of the Board Chief Executive Officer Marketing & Communication Director + 33 (0)6 88 69 72 85
CONTACTS ULYSSE COMMUNICATION Bruno ARABIAN Nicolas DANIELS [email protected] [email protected] +33 (0)6 87 88 46 26 +33 (0)6 63 66 59 22
